New weekly shot shows promise for shedding pounds in obesity trial
NCT ID NCT06214741
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new medicine called survodutide in 307 Chinese adults with obesity or overweight. Participants received weekly injections of either survodutide or a placebo for about 19 months. The main goals were to see how much weight people lost and if at least 5% of body weight was reduced after one year. The study is complete, and results will show if survodutide is a safe and effective treatment for weight management.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Hospital of Nantong University
Nantong, 226001, China
-
Beijing Chao-Yang Hospital
Beijing, 100020, China
-
Beijing Pinggu Hospital
Beijing, 101200, China
-
Center Hospital of Jinan
Jinan, 250013, China
-
Changzhou Second People's Hospital
Changzhou, 213004, China
-
Forth Clinical Hospital of Harbin Medical University
Harbin, 150599, China
-
Huzhou Central Hospital
Huzhou, 313000, China
-
Jincheng General Hospital
Jincheng, 048000, China
-
Lishui Municipal Central Hospital
Lishui, 323020, China
-
NanFang Hosptial
Guangzhou, 510515, China
-
Panjin Liao Oil Gem Flower Hospital
Panjin, 124000, China
-
Peking University People's Hospital
Beijing, 100044, China
-
People's Hospital of Sichuan Province
Chengdu, 610072, China
-
Second Affiliated Hospital Chongqing Medical University
Chongqing, 400016, China
-
Shanghai Fifth People's Hospital affiliated to Fudan University
Shanghai, 200240, China
-
Siping Central People's Hospital
Siping, 136000, China
-
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, 471000, China
-
The First Affiliated Hospital of Ningbo University
Ningbo, 315010, China
-
The First Affiliated Hospital of Xi'an Medical University
Xi'an, 710077, China
-
The First Hospital of Jilin University
Changchun, 130021, China
-
The People's Hospital Of Xuancheng City
Xuancheng, 242000, China
-
The Second Affiliated Hospital of Nanjing Medical University
Nanjing, 210011, China
-
The Second Hospital of Jilin University
Changchun, 130041, China
-
Tianjin Medical University Chu Hisen-I Memorial Hospital
Tianjin, 300070, China
-
Tianjin Medical University General Hospital
Tianjin, 30052, China
-
Wuhan Union Hospital
Wuhan, 430022, China
-
Yichang Central People's Hospital
Yichang, 443000, China
-
Yueyang People's Hospital
Yueyang, 414109, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?
- Can stomach surgery alter how painkillers work?